SARS-CoV-2 Serological Antibody Testing for Disease Surveillance and Clinical Use

Kaiser Foundation Research Institute, Oakland CA

Investigators

Linked publications, trials & patents

Abstract

We propose a two-year collaborative project to synchronize data harmonization efforts and analyses of individual-level data in immunocompromised populations to assess effectiveness of vaccine boosters and immune responses using data from 11 Serological Sciences Network (SeroNet) institutions. Our goal is to inform public health guidelines on COVID-19 vaccine and boosters to reduce SARS-CoV-2 infection and severe illness in these vulnerable populations.